SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-145220
Filing Date
2023-05-15
Accepted
2023-05-15 17:23:59
Documents
12
Period of Report
2023-05-15
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d443156d8k.htm   iXBRL 8-K 21818
  Complete submission text file 0001193125-23-145220.txt   142632

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA chrs-20230515.xsd EX-101.SCH 2850
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE chrs-20230515_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE chrs-20230515_pre.xml EX-101.PRE 11261
6 EXTRACTED XBRL INSTANCE DOCUMENT d443156d8k_htm.xml XML 3362
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36721 | Film No.: 23924477
SIC: 2836 Biological Products, (No Diagnostic Substances)